Author:
Publisher: DIANE Publishing
ISBN: 1428983341
Category :
Languages : en
Pages : 248
Book Description
Department of Defense Chemical, Biological, Radiological, and Nuclear Defense Program: Annual Report to Congress 1999
Author:
Publisher: DIANE Publishing
ISBN: 1428983341
Category :
Languages : en
Pages : 248
Book Description
Publisher: DIANE Publishing
ISBN: 1428983341
Category :
Languages : en
Pages : 248
Book Description
The Anthrax Vaccine
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309182743
Category : Medical
Languages : en
Pages : 288
Book Description
The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA. The Anthrax Vaccine: Is It Safe? Does It Work? reports the study's conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine.
Publisher: National Academies Press
ISBN: 0309182743
Category : Medical
Languages : en
Pages : 288
Book Description
The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA. The Anthrax Vaccine: Is It Safe? Does It Work? reports the study's conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine.
V&B Annual Report
Author: World Health Organization. Department of Vaccines and Other Biologicals
Publisher:
ISBN:
Category : Biologicals
Languages : en
Pages : 318
Book Description
Publisher:
ISBN:
Category : Biologicals
Languages : en
Pages : 318
Book Description
Adverse Effects of Vaccines
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309214351
Category : Medical
Languages : en
Pages : 894
Book Description
In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors.
Publisher: National Academies Press
ISBN: 0309214351
Category : Medical
Languages : en
Pages : 894
Book Description
In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors.
Chemical and Biological Defense Program Annual Report to Congress
Author:
Publisher:
ISBN:
Category : Biological warfare
Languages : en
Pages : 286
Book Description
Publisher:
ISBN:
Category : Biological warfare
Languages : en
Pages : 286
Book Description
Health Services in Latin America and Asia
Author: José Núñez del Arco
Publisher: IDB
ISBN: 9781931003100
Category : Medical
Languages : en
Pages : 336
Book Description
On either side of the globe, poor people often do not have access to the health services they need. Improvements in health care systems in Asia have lagged behind economic development, and progress in expanding health coverage in Latin America has been skewed across income levels. Health Services in Latin America and Asia takes a close look at how countries in both regions provide health care services, including the strategies that work and the problems that persist. The book documents encouraging progress in Bolivia, Brazil, China and Vietnam, and important preventive care programs in Central America and Thailand. It also examines health services in Chile, Colombia, the Philippines and Malaysia, as well as the health system and insurance model in Japan.Even though public and preventive health require specific and sustained allocations, both regions continue to use health insurance and other supply mechanisms to expand health service coverage. The book recommends broadening the supply of services through family doctors and community health workers, an alternative approach that would likely improve the equity, efficiency and sustainability of services.
Publisher: IDB
ISBN: 9781931003100
Category : Medical
Languages : en
Pages : 336
Book Description
On either side of the globe, poor people often do not have access to the health services they need. Improvements in health care systems in Asia have lagged behind economic development, and progress in expanding health coverage in Latin America has been skewed across income levels. Health Services in Latin America and Asia takes a close look at how countries in both regions provide health care services, including the strategies that work and the problems that persist. The book documents encouraging progress in Bolivia, Brazil, China and Vietnam, and important preventive care programs in Central America and Thailand. It also examines health services in Chile, Colombia, the Philippines and Malaysia, as well as the health system and insurance model in Japan.Even though public and preventive health require specific and sustained allocations, both regions continue to use health insurance and other supply mechanisms to expand health service coverage. The book recommends broadening the supply of services through family doctors and community health workers, an alternative approach that would likely improve the equity, efficiency and sustainability of services.
Chemical and Biological Defense Program annual report to Congress (2000)
Author:
Publisher: DIANE Publishing
ISBN: 1428980997
Category :
Languages : en
Pages : 272
Book Description
This Annual Report of the Department of Defense (DOD) Chemical and Biological Defense Program (CBDP) provides information in response to several reporting requirements. First, this report is provided in accordance with 50 U.S. Code Section 1523. (The complete reporting requirement is detailed at Annex L) This report is intended to assess: (1) the overall readiness of the Armed Forces to fight in a chemical biological (CB) warfare environment and steps taken and planned to be taken to improve such readiness; and, (2) requirements for the chemical and biological warfare defense program, including requirements for training, detection, and protective equipment, for medical prophylaxis, and for treatment of casualties resulting from use of chemical and biological weapons. The CBDP provides an integrated collection of chemical and biological defense systems to U.S. forces. The overall readiness of U.S. forces is dependent on many factors. One key factor is the availability of equipment. Chapter 2 summarizes equipment requirements and the status of research, development, test and evaluation (RDT & E) and acquisition efforts across all capability areas. Chapter 3 details the logistics status of CB defense systems. The overall logistical readiness status of the Department's CB defense equipment has improved slightly. Several factors have had an adverse effect on the overall DOD readiness and sustainment status: increased demands by the Services for some CB defense equipment; the increased overall Service requirements in order to support operations in Iraq and Afghanistan; the reorganization and the approved strength increase of the Army; and equipment modernization efforts in all of the Services. Another key factor in overall readiness is the education, training, and exercises conducted by U.S. forces to remain prepared for chemical and biological threats. Education, training, and exercises are detailed in Chapter.
Publisher: DIANE Publishing
ISBN: 1428980997
Category :
Languages : en
Pages : 272
Book Description
This Annual Report of the Department of Defense (DOD) Chemical and Biological Defense Program (CBDP) provides information in response to several reporting requirements. First, this report is provided in accordance with 50 U.S. Code Section 1523. (The complete reporting requirement is detailed at Annex L) This report is intended to assess: (1) the overall readiness of the Armed Forces to fight in a chemical biological (CB) warfare environment and steps taken and planned to be taken to improve such readiness; and, (2) requirements for the chemical and biological warfare defense program, including requirements for training, detection, and protective equipment, for medical prophylaxis, and for treatment of casualties resulting from use of chemical and biological weapons. The CBDP provides an integrated collection of chemical and biological defense systems to U.S. forces. The overall readiness of U.S. forces is dependent on many factors. One key factor is the availability of equipment. Chapter 2 summarizes equipment requirements and the status of research, development, test and evaluation (RDT & E) and acquisition efforts across all capability areas. Chapter 3 details the logistics status of CB defense systems. The overall logistical readiness status of the Department's CB defense equipment has improved slightly. Several factors have had an adverse effect on the overall DOD readiness and sustainment status: increased demands by the Services for some CB defense equipment; the increased overall Service requirements in order to support operations in Iraq and Afghanistan; the reorganization and the approved strength increase of the Army; and equipment modernization efforts in all of the Services. Another key factor in overall readiness is the education, training, and exercises conducted by U.S. forces to remain prepared for chemical and biological threats. Education, training, and exercises are detailed in Chapter.
Indexes for Abstracts of Reports and Testimony
Author:
Publisher:
ISBN:
Category : Finance, Public
Languages : en
Pages : 368
Book Description
Publisher:
ISBN:
Category : Finance, Public
Languages : en
Pages : 368
Book Description
Department of Defense Chemical, Biological, Radiological, and Nuclear Defense Program: Annual Report to Congress 2000
Author:
Publisher: DIANE Publishing
ISBN: 1428983333
Category :
Languages : en
Pages : 272
Book Description
Publisher: DIANE Publishing
ISBN: 1428983333
Category :
Languages : en
Pages : 272
Book Description
Department of Defense Anthrax Vaccine Immunization Program
Author: United States. Congress. Senate. Committee on Armed Services
Publisher:
ISBN:
Category : Anthrax
Languages : en
Pages : 248
Book Description
Publisher:
ISBN:
Category : Anthrax
Languages : en
Pages : 248
Book Description